Next Article in Journal
Subcritical Water Extraction Enables the Production of Cichoric and Caftaric Acid-Standardized Echinacea purpurea Root Extracts with Defined Composition and Favorable Biological Properties
Previous Article in Journal
Physics-Informed Machine Learning for Optimized and Sustainable Biochar Water Treatment
Previous Article in Special Issue
Chemical Constituents Comparison Between the Flowers of Sophora japonica L. and Robinia pseudoacacia L. by UPLC-Q-TOF-MS/MS and HPLC
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Characteristic Constituents of Maocangzhu and Beicangzhu Revealed Using Electronic Nose, Electronic Tongue, HS-GC-IMS, and UPLC-Orbitrap Technologies

1
Institute of Pharmacy (Institute of TCM Health Industrial Technology), Shandong University of Traditional Chinese Medicine, Jinan 250355, China
2
Shandong Key Laboratory of Digital Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan 250355, China
*
Author to whom correspondence should be addressed.
Molecules 2026, 31(13), 2350; https://doi.org/10.3390/molecules31132350
Submission received: 6 May 2026 / Revised: 17 June 2026 / Accepted: 29 June 2026 / Published: 3 July 2026

Abstract

Atractylodis Rhizoma is an important traditional Chinese medicinal material derived from two botanical origins, Maocangzhu (MCZ) and Beicangzhu (BCZ), which are difficult to distinguish by conventional morphological identification because of their similar appearance. However, differences in botanical origin may lead to variations in odor, taste, volatile constituents, and non-volatile metabolites, thereby affecting quality evaluation and clinical application. This study aimed to systematically characterize the sensory and chemical differences between MCZ and BCZ and to identify potential markers for their discrimination. A multi-dimensional analytical strategy combining electronic nose, electronic tongue, headspace gas chromatography–ion mobility spectrometry (HS-GC-IMS), and ultra-high-performance liquid chromatography–Orbitrap high-resolution mass spectrometry (UPLC-Orbitrap MS) was established. Electronic nose and electronic tongue were used to digitize odor and taste characteristics, HS-GC-IMS was employed to profile volatile organic compounds, and UPLC-Orbitrap MS was applied to characterize non-volatile metabolites. Principal component analysis (PCA), orthogonal partial least squares discriminant analysis (OPLS-DA), variable importance in projection (VIP) screening, permutation tests, and correlation analysis were further used to evaluate discrimination performance and screen characteristic markers. The electronic nose results showed that MCZ and BCZ exhibited distinct odor profiles, with W5S, W1W, and W1S identified as the main differential sensors, suggesting that nitrogen oxides, terpenoids, inorganic sulfides, and short-chain alkanes contributed to the odor differences between the two origins. Electronic tongue analysis further demonstrated clear taste discrimination, with sourness and richness identified as the key taste indicators. HS-GC-IMS detected 108 volatile organic compounds, and 24 volatile markers with VIP > 1.2 were screened as important contributors to the differentiation of MCZ and BCZ. Among them, propionic acid and 5-methyl-2-furancarboxaldehyde were mainly distributed in MCZ, whereas (E)-caryophyllene was present only or at higher levels in BCZ, indicating its potential as a characteristic volatile marker of BCZ. UPLC-Orbitrap MS detected 78 non-volatile constituents, and OPLS-DA screened 17 key non-volatile differential metabolites with VIP > 1.2. These results indicated that MCZ and BCZ could be clearly separated not only by sensory signals but also by volatile and non-volatile chemical profiles. This study revealed that the differences between MCZ and BCZ are mainly reflected in odor-active volatile compounds, key taste indicators, and non-volatile differential metabolites. The integration of electronic nose, electronic tongue, HS-GC-IMS, and UPLC-Orbitrap MS provides a comprehensive and reliable strategy for distinguishing the two botanical origins of Atractylodis Rhizoma. These findings provide valuable insights into the material basis underlying the sensory and chemical differences between MCZ and BCZ and offer scientific support for accurate authentication, quality evaluation, and rational clinical application of Atractylodis Rhizoma.

1. Introduction

Atractylodis Rhizoma is an important traditional Chinese medicinal material derived from the dried rhizomes of two Asteraceae species, Atractylodes lancea (Thunb.) DC. and Atractylodes chinensis (DC.) Koidz. In China, A. lancea is commonly known as Maocangzhu and is abbreviated as MCZ, whereas A. chinensis is commonly known as Beicangzhu and is abbreviated as BCZ. MCZ, also known as Nancangzhu, is mainly distributed in Jiangsu, Hubei, and Henan provinces of China, with the Maoshan region in Jiangsu Province traditionally recognized as an authentic production area. BCZ, also known as Shancangzhu, is primarily produced in Jilin, Liaoning, Inner Mongolia and Hebei provinces of China [1]. According to traditional Chinese medicine theory, Atractylodis Rhizoma has the effects of drying dampness, strengthening the spleen, dispelling wind, relieving cold, and improving vision. Modern pharmacological studies have reported that Atractylodis Rhizoma possesses multiple bioactivities, including antitumor [2], antibacterial [3], anti-inflammatory [4], and immunomodulatory effects [5].
Although MCZ and BCZ are both botanical origins of Atractylodis Rhizoma, their chemical compositions may differ because of genetic background, geographical distribution, and growth environment [6]. However, the two herbal materials are highly similar in external morphology, and conventional identification methods based mainly on appearance, odor, and empirical experience are often insufficient for accurate discrimination. This may lead to misidentification or mixed use in herbal markets and clinical practice, thereby affecting quality consistency and clinical efficacy. Therefore, it is necessary to establish reliable analytical methods for distinguishing MCZ from BCZ and to clarify the characteristic constituents responsible for their differences.
Atractylodis Rhizoma has a complex chemical profile, containing volatile constituents such as essential oils and terpenoids, as well as non-volatile constituents such as sesquiterpenes, polysaccharides, phenolic acids, and other secondary metabolites. Conventional analytical methods, such as gas chromatography–mass spectrometry (GC-MS), can effectively characterize essential oils [7]. However, these methods usually require relatively complex sample preparation and longer analysis time, which may limit their suitability for high-throughput rapid screening. Headspace gas chromatography–ion mobility spectrometry (HS-GC-IMS) combines chromatographic separation with ion mobility detection, enabling relatively rapid analysis of volatile organic compounds (VOCs) with simplified sample pretreatment. It is particularly suitable for detecting small-molecule VOCs and has been increasingly applied in the analysis of traditional Chinese medicines [8].
In addition to chemical profiling, sensory characteristics such as odor and taste are important features traditionally used in the identification and quality evaluation of Chinese medicinal materials. Electronic nose and electronic tongue technologies provide objective, reproducible, and digitalized evaluation of odor and taste, helping reduce the subjectivity associated with manual sensory assessment. These biomimetic techniques have shown considerable potential in quality control and authenticity evaluation of traditional Chinese medicines [9]. Meanwhile, Orbitrap mass spectrometry, characterized by high resolution, broad spectral coverage, and excellent mass accuracy, enables reliable multistage mass spectrometric analysis of complex samples and has been widely used for chemical component characterization [10,11].
Given the complexity of Atractylodis Rhizoma, a single analytical technique is insufficient to comprehensively reveal the differences between MCZ and BCZ. Therefore, the aim of this study was to systematically compare the two botanical origins by integrating electronic nose, electronic tongue, HS-GC-IMS, and UPLC-Orbitrap MS from sensory, volatile, and non-volatile perspectives, and to identify the characteristic constituents distinguishing MCZ from BCZ, thereby providing a scientific basis for the accurate authentication, quality evaluation, and rational utilization of Atractylodis Rhizoma.

2. Results

2.1. HS-GC-IMS Analysis of Volatile Metabolites

2.1.1. Identification of Major Volatile Metabolites in Atractylodes Samples Based on HS-GC-IMS

Figure 1 presents the three-dimensional (3D) surface characteristics of volatile metabolites identified in Atractylodis Rhizoma samples from different sources. The X, Y, and Z axes of the 3D plot correspond to migration time, retention time, and peak intensity, respectively. The 3D plots reveal pronounced differences in the types and concentrations of volatile organic compounds between BCZ and MCZ. For clearer comparison among samples, a differential comparison mode was used: each point represents a specific volatile organic compound, and the color intensity reflects concentration, with darker shades indicating higher concentrations. The spectrum of BCZ was set as the reference, with the spectrum of MCZ subtracted from it. Red signifies a higher concentration than the reference, while blue signifies a lower concentration. The results from the differential comparison spectrum (Figure 2) confirm differences in both component types and concentrations between MCZ and BCZ, consistent with the observations from the 3D spectrum.
Following background subtraction, chromatographic peak extraction, and peak alignment of the GC-IMS data from MCZ and BCZ samples, a total of 108 active components were identified and qualitatively analyzed (Table 1). These components primarily include esters, aldehydes, ketones, alcohols, and acids. Specifically, there were 13 aldehydes (12.04%), 14 ketones (12.96%), 21 alcohols (19.44%), 23 esters (21.30%), 4 carboxylic acids (3.70%), 8 phenols (7.41%), 6 alkenes (5.56%), 7 nitrogen-containing compounds (6.48%), 4 sulfur-containing compounds (3.70%), and 8 other compounds (7.41%). Some of these compounds are present as both monomers and dimers.

2.1.2. Analysis of Major Volatile Metabolites in Atractylodes Samples Using HS-GC-IMS

2-Hexen-1-ol, geraniol, and α-Terpinolene are major alcohol-type volatile metabolites in Atractylodes (Figure 3b). 2-Hexen-1-ol is a nearly colorless liquid with a strong odor reminiscent of unripe fruit. Studies have shown that 2-hexen-1-ol exhibits inhibitory effects against Fusarium species infecting stored corn grains [12]. Geraniol, a monoterpenol with a rose-like fragrance, is widely used in cosmetics and high-end perfumes; it also demonstrates antibacterial [13], anticancer [14], neuroprotective [15,16], and antioxidant activities. α-Terpineol is a monocyclic monoterpene alcohol commonly found in the essential oils of various aromatic plants. It has been reported to possess a broad spectrum of biological activities, including anticancer, anti-inflammatory, and analgesic properties. α-Terpineol has been demonstrated to exert anticancer effects by suppressing NF-κB signaling and inducing apoptosis in tumor cells [17]. Moreover, its antinociceptive and anti-inflammatory effects have been validated in neuropathic pain models, where it significantly attenuated mechanical allodynia and hyperalgesia through the inhibition of spinal microglial activation and inflammatory cytokines [18].
Other bioactive compounds have also been identified among the volatile alcohol metabolites of Atractylodes, contributing to its complex and unique chemical profile and biological functions.
Linalyl acetate, Methyl anthranilate, ethyl 4-methoxybenzoate, and Linalyl isobutyrate together accounted for 50.6% of all ester compounds detected in this study (Figure 3c). Linalyl acetate is a monoterpene compound and the acetate ester of linalool, constituting a major component of bergamot and lavender essential oils. Its biological activity is closely related to that of linalool, and it may help alleviate psoriasiform inflammation by interfering with IL-12-driven inflammatory responses, mainly acting on Th-1 cell-specific cytokines [19]. Methyl anthranilate may inhibit the quorum sensing system in Pseudomonas aeruginosa by interfering with AHL biosynthesis and competitively binding to receptor proteins. It shows promise as a quorum sensing inhibitor and anti-biofilm agent, with potential for improving food safety [20]. Ethyl 4-methoxybenzoate is a colorless, oily liquid with a sweet, anise-like aroma. Occurring naturally in apple brandy, plums, and white wine, it is primarily used as a fragrance ingredient in cosmetics and perfumes. Safety evaluations indicate it poses no health risks, such as genotoxicity or skin sensitization, at current usage levels and is safe for the aquatic environment [21]. Linalyl isobutyrate is a colorless to pale yellow liquid with a sweet, fresh, rose-like scent, widely used as a fragrance ingredient in perfumes, cosmetics, and personal care products [22].
4-ethylbenzaldehyde and cuminaldehyde are primary aldehyde components. 4-ethylbenzaldehyde is a colorless to pale yellow liquid with a sweet, bitter almond scent. It occurs naturally in various foods such as prickly ash, dairy products, and peanuts, and is used as a fragrance ingredient in products like lip care items, perfumes, and air fresheners [23]. Cuminaldehyde, also a colorless to pale yellow liquid, has a strong, pungent, spicy, green herbal odor. As a bioactive component of essential oils, cuminaldehyde shows potential for analgesic, anti-inflammatory, and antibacterial applications [24,25,26]. Cuminaldehyde exerts analgesic and neuroprotective effects via opioid receptors, the L-arginine/NO/cGMP/KATP signaling pathway, and anti-inflammatory functions. It can modulate immune responses in inflammation and may be considered a lead compound for novel anti-inflammatory and analgesic drug development [24,25].

2.1.3. HS-GC-IMS-Based Volatile Organic Compound Fingerprint Analysis of Atractylodes Samples

To further examine the differences between BCZ and MCZ, the Gallery Plot plugin was employed for a visual comparison of volatile organic compounds among various samples. All peaks were included for fingerprint analysis; in the figure, each row corresponds to all signal peaks from a single sample, and each column represents the signal peaks of the same volatile organic compound across different samples. Fingerprint spectra were constructed for BCZ and MCZ, as shown in Figure 4. A deeper red indicates a higher concentration of that component. The samples display both unique characteristic signals and shared common signals.
As illustrated in Figure 4, the components in regions A, C, and E are mainly concentrated in MCZ samples, including propionic acid and 5-methyl-2-furancarboxaldehyde, which may serve as volatile markers to differentiate BCZ from MCZ. The volatile profiles of batches 3 and 4 of BCZ are relatively similar in region A, while region E highlights the similarity between batches 1 and 2. Components in region B are present at higher levels in BCZ compared to MCZ. Region D includes 42 compounds common to both species. Region F comprises components found exclusively or at higher concentrations in MCZ; among these, (E)-Caryophyllene is unique to BCZ, consistent with previous literature [27], and can serve as a key marker for distinguishing between the two species.

2.1.4. Multivariate Statistical Analysis Based on HS-GC-IMS

The PCA scatter plot (see Figure 5) shows no clear separation between MCZ and BCZ samples, indicating that the data (variables and samples) used in this analysis were insufficient for PCA to clearly demonstrate the differences between these two categories. In contrast, the OPLS-DA scatter plot demonstrates a clear separation trend, suggesting that this model can reliably differentiate between MCZ and BCZ. Model assessment revealed that the cumulative explanatory power of independent variables (R2X) was 0.749, the goodness-of-fit for dependent variables (R2Y) was 0.994, and the predictive capability parameter (Q2) was 0.977. Both R2 and Q2 values are close to 1, reflecting excellent model fit and predictive reliability. The model’s robustness was further confirmed by a 200-permutation test, yielding a Q2 intercept of −1.15 (less than 0), indicating the model is not overfitted and remains stable and valid.
Using a VIP > 1.2 criterion, 24 volatile biomarkers were identified as significant contributors to differentiation between the two sample types, including: FCC (dimer), carvone (dimer), linalyl isobutyrate (monomer), dimethylformamide (DMF), (E)-3-hexen-1-ol, 3-methylbutyraldehyde, methyl anthranilate, α-terpineol, acetyl furfuryl ester, (E,E)-α-Farnesene, 4-methoxybenzyl alcohol, 4-vinylguaiacol, 2-butanone, 1-phenylethyl acetate, eugenol methyl ether, 3-δ-carene, 2,6-di-tert-butyl-4-methylphenol (monomer), (E)-2-hexenal, (E)-Caryophyllene, (E)-3-hexenoic acid, 2-pentanol, 2-hydroxy-3-methyl-2-cyclopent-1-enone, 2-methoxy-3-sec-butylpyrazine, and 2-Octanone.

2.2. UPLC-Orbitrap Analysis of Non-Volatile Metabolites

2.2.1. Identification of Major Non-Volatile Metabolites in Atractylodes Samples Using UPLC-Orbitrap

High-resolution mass spectrometry (HRMS) analysis was conducted using ESI, alternating between positive and negative ion modes, with a full MS/ddMS2 scan mode (Figure 6). Compound identification was achieved by comparing characteristic ion fragmentation patterns against in-house databases (mzCloud and mzVault), the PubChem online database (https://pubchem.ncbi.nlm.nih.gov/), and literature data. A total of 78 chemical constituents were identified (Table 2), including terpenes (15), organic acids and their esters (38), coumarins (4), lignans (2), flavonoids (2), sugars and glycosides (8), amides (5), and other components (4).

2.2.2. Analysis of Major Non-Volatile Metabolites in Atractylodes Samples Using UPLC-Orbitrap

Terpenoids are the signature metabolites of Atractylodes. Atractylone is a characteristic compound of Atractylodes from authentic production areas, with demonstrated antitumor and anti-inflammatory properties [28,29]. Zedoarondiol has demonstrated anti-inflammatory effects [30] and anti-atherosclerotic activity [31]. Caryophyllene oxide exhibits multiple pharmacological activities, including anti-inflammatory, antioxidant, and antitumor effects [32,33,34,35]. Nootkatone (NKT) displays a range of biological activities, such as anti-inflammatory, anticancer, antibacterial, and neuroprotective effects [36,37,38,39,40].
Organic acids and their esters: Quinic acid demonstrates a variety of pharmacological activities, including antioxidant, antibacterial, anti-inflammatory, antiviral, and antitumor effects [41,42]. Chlorogenic acid also exhibits significant biological activities, such as anti-inflammatory, immunomodulatory, glucose- and lipid-lowering, antibacterial, and antitumor effects [43,44,45,46,47], making it highly applicable in medicine, healthcare, food, cosmetics, and as an alternative to antibiotics in animal feed. Arginine displays immunomodulatory, antioxidant, and lipid-lowering properties, as well as anti-inflammatory effects [48,49,50].
Coumarins and flavonoids: The coumarin compounds scopoletin and scoparone possess anticoagulant and vasoprotective effects [51,52,53,54]. The flavonoids daidzein and puerarin are notable for their antioxidant and anti-inflammatory properties, garnering significant scientific interest [55,56].
The active metabolites of Atractylodes are mainly terpenoids (zedoarondiol, atractylone, and NKT), alongside phenolic acids (chlorogenic acid, caffeic acid), coumarins (scopoletin, scoparone), and flavonoid glycosides (puerarin). Together, these compounds form the pharmacological basis for the herb’s traditional effects of “strengthening the spleen, drying dampness, and providing anti-inflammatory and hepatoprotective actions”. These results are highly consistent with modern pharmacological interpretations of Atractylodes’ traditional uses [57], supporting its application in metabolic and digestive system disorders.

2.2.3. Multivariate Statistical Analysis Based on UPLC-Orbitrap

As shown in Figure 7a, although the PCA score plot can preliminarily distinguish between the two types of Atractylodes samples, its cumulative explanatory power is only 50.4%, indicating that PCA alone has limited ability to differentiate between varieties. In contrast, the OPLS-DA score plot in Figure 7b shows a strict separation boundary along the predicted component axis (t[1]): all BCZ samples (BCZ1–BCZ6) are distributed on the right, while all MCZ samples (MCZ1–MCZ6) are on the left, with no overlap, visually confirming the model’s high discriminatory capability. The OPLS-DA model (M3) explains 64.9% of the variance in the original data (R2X = 0.649), achieves a near-perfect fit for the classification labels (R2Y = 0.999), and its predictive power (Q2 = 0.946) markedly surpasses that of PCA (Q2 = 0.214) and PLS-DA (Q2 = 0.870). After a 200-permutation test, the R2 regression line intercept (0.969) was much lower than the original, and the Q2 regression line intercept (−0.591) was below zero, confirming that the model is valid and not overfitted as Figure 7c.
In this study, an OPLS-DA model was established to distinguish Atractylodes varieties based on non-volatile metabolites. The model’s performance was systematically validated through key statistical parameters and visualization. Furthermore, 17 non-volatile metabolites were identified as significant differentiators using UPLC-Orbitrap data with a VIP > 1.2 criterion as Figure 7d.

2.3. Electronic Nose Analysis Results

2.3.1. Odor Composition Analysis of Northern Atractylodes and Maocang Atractylodes

The average response values of electronic nose sensors for MCZ and BCZ samples were analyzed, and a radar chart was generated to visually illustrate the differences between the samples. As shown in Figure 8, all 10 sensors responded to the samples, with sensors W5S and W1W showing particularly strong responses. This suggests that both MCZ and BCZ contain higher levels of nitrogen oxides, terpenes, and inorganic sulfides, which are likely the main contributors to the odor differences between these species.

2.3.2. Analysis of Contribution Rates to Sensor Discrimination via Loadings

Loadings analysis distinguishes the volatile components that play a primary role in each sample. As shown in Figure 9, the contribution rate of sensor response values for PC1 is 68.45% and for PC2 is 16.40%, with a cumulative contribution rate of 84.85%. Among these, W5S (Sensor No. 2) contributed most to discriminating the first principal component, while W1W (Sensor No. 7) contributed most to the second principal component. Based on the response characteristics, the first principal component is mainly sensitive to nitrogen oxides, and the second principal component to terpenes and inorganic sulfides. These findings are consistent with the earlier sensor response analysis.

2.3.3. Multivariate Statistical Analysis Based on the Electronic Nose

Multivariate statistical analysis was performed using SIMCA 14.1 software for OPLS-DA analysis, with VIP > 1 as the screening criterion. Additionally, 200 bootstrap tests were conducted on the OPLS-DA models. As shown in Figure 10, after bootstrapping, the R2 and Q2 values on the right were higher than the original points on the left, indicating that the models did not suffer from overfitting and could reliably discriminate between BCZ and MCZ. The results show that the two species cluster into distinct groups: MCZ is mainly distributed in the first and fourth quadrants, and BCZ in the first and third quadrants. Using VIP > 1, three differentially responsive sensors (W1W, W5S, W1S) were identified.
Analysis of the electronic nose data indicates significant differences in odor characteristics between BCZ and MCZ, mainly reflected in the responses of sensors W5S, W1W, and W1S. Nitrogen oxides, terpenes, inorganic sulfides, and short-chain alkanes such as methane are the key volatile components distinguishing the two species.

2.4. Electronic Tongue Analysis Results

2.4.1. Analysis of Taste Composition of BCZ and MCZ

Figure 11 presents the radar chart of electronic tongue sensor response intensities to BCZ and MCZ samples. The results indicate that neither sample exhibits sourness, but both show relatively high umami and bitterness values. This aligns with the description of Atractylodes as “bitter” in the 2025 edition of the Chinese Pharmacopoeia.

2.4.2. Multivariate Statistical Analysis Based on the Electronic Tongue

The electronic tongue sensor response values for BCZ and MCZ were analyzed using SIMCA 14.1 software for PCA. The results (Figure 12) show that the two species can be clustered into separate groups, indicating that the electronic tongue can distinguish Atractylodes from different origins.
To further identify distinguishing features between MCZ and BCZ, OPLS-DA analysis was performed on electronic tongue response values using SIMCA 14.1 software. With VIP > 1 as the criterion and 200 bootstrap tests, the results (Figure 12) show that the model is stable, reliable, and has strong predictive power without overfitting. The OPLS-DA plot shows that different Atractylodes species cluster into distinct groups, consistent with PCA results. Two discriminant features—sourness and richness—were identified. It should be noted that although the absolute sourness sensor response values were low for both BCZ and MCZ (Figure 11), the sourness sensor still generates a measurable electrical response, and the subtle difference in this response between MCZ and BCZ was statistically significant, which led to its identification as a discriminant feature by OPLS-DA (VIP > 1). In other words, electronic tongue sensors detect electrochemical signals rather than human taste perception; a statistically significant sensor difference does not necessarily indicate a perceptible taste difference at the human sensory threshold. Nevertheless, these subtle sensor-level differences, when combined with other taste attributes through multivariate modeling, contribute to the overall discrimination between the two species.
This study analyzed the flavor data of MCZ and BCZ and performed PCA using characteristic indicators. The results showed that the two species can be reliably distinguished by origin. OPLS-DA analysis further confirmed that flavor characteristics play a significant role in distinguishing Atractylodes origins. These findings provide a reference for origin identification and quality evaluation of Atractylodes.

2.5. Pearson Correlation Analysis of “Composition-Odor”

To further investigate the relationship between volatile metabolites and electronic nose sensor responses, a correlation analysis was conducted between major differentially expressed volatile metabolites and the sensors showing strong responses (W1W, W5S, and W1S). Twenty-four volatile metabolites with VIP > 1.2 were selected for correlation analysis with these three sensors.
The results (Figure 13) show that sensor W1W has a significant positive correlation with 3-methylbutyraldehyde (C6) (p < 0.05). Although W1W is sensitive to terpenes and inorganic sulfides, 3-methylbutyraldehyde—a short-chain aldehyde—may have produced a cross-response due to its molecular structure or sensor-surface interactions. No significant correlation was found between sensor W5S and any component (p > 0.05). Sensor W1S showed significant positive correlations with linalool (C1), carvone (C2), 4-vinylguaiacol (C12), 2-butanone (C13), 2,6-di-tert-butyl-p-cresol (C17), 2-pentanol (C21), and 2-methoxy-3-sec-butylpyrazine (C23), and significant negative correlations with farnesene (C10), δ-3-carene (C16), and 3-cyclopentene-1-one (C22).
Based on these findings, the main chemical basis for odor differences among the samples is attributed to short-chain oxygen-containing compounds (such as alcohols, ketones, and aldehydes) and terpenoids. Linalool, carvone, 4-vinylguaiacol, and 2-methoxy-3-sec-butylpyrazine produce strong positive responses on sensor W1S and are key contributors to the characteristic odors of the samples, while terpenes like farnesene and δ-3-carene may suppress or modify overall odor. Sensor W1S responds to the majority of differential components, making it the most critical sensor for distinguishing the odor characteristics of the samples.

2.6. Double Cross-Validation of OPLS-DA Models

Double cross-validation (2CV) was performed to rigorously evaluate the predictive ability of each OPLS-DA model. In Table 3, the 2CV Q2 values confirmed the robust predictive ability of all four OPLS-DA models, with 2CV Q2 of 0.624, 0.996, 0.880, and 0.878 for the E-nose, E-tongue, HS-GC-IMS, and UPLC-Orbitrap MS models, respectively. The classification accuracies ranged from 91.67% to 100%. All permutation test Q2 intercepts were negative, confirming that none of the models suffered from overfitting.

3. Discussion

This study integrated electronic nose, electronic tongue, HS-GC-IMS, and UPLC-Orbitrap MS to systematically analyze the sensory characteristics and chemical compositions of MCZ and BCZ. The results revealed significant differences between the two botanical origins in odor, taste, volatile compounds, and non-volatile metabolites.
HS-GC-IMS identified 108 volatile organic compounds, with 24 key volatile markers screened out, which contributed significantly to the differentiation of MCZ and BCZ. Notably, propionic acid and 5-methyl-2-furancarboxaldehyde were predominantly found in MCZ, while (E)-caryophyllene was enriched in BCZ, suggesting these compounds as potential volatile markers for distinguishing the two botanical origins. Ma et al. employed GC-MS coupled with chemometric analysis to differentiate four Atractylodes species, identifying 50 volatile components from 59 batches of samples and screening out hinesol, β-eudesmol, atractylon, atractylodin, and atractylenolide I as species characteristic markers [7]. However, traditional GC-MS analysis typically relies on hydrodistillation, which may cause loss or transformation of thermally labile compounds. In contrast, HS-GC-IMS requires no complex sample pretreatment and can more authentically reflect the original volatile profile. This technical advantage is particularly important for distinguishing botanical origins with subtle differences in volatile composition. Compared with conventional GC-MS, HS-GC-IMS offers advantages such as rapid analysis, minimal sample pretreatment, and high sensitivity for volatile organic compounds; however, its compound library is relatively limited compared to the well-established NIST mass spectral database used in GC-MS [58,59]. Therefore, combining both techniques provides a more comprehensive approach for Atractylodes quality evaluation.
Furthermore, UPLC-Orbitrap MS detected 78 non-volatile constituents, with 17 differential metabolites screened out by OPLS-DA with VIP > 1.2. Li et al. applied UHPLC-Orbitrap-HRMS for non-targeted metabolomics analysis of A. chinensis from eight origins, confirming significant metabolic variations among different regions [60]. These findings indicate that MCZ and BCZ can be effectively discriminated based on both sensory signals and chemical profiles, including volatile and non-volatile constituents.
Sensory technologies are also widely used in botanical origin identification. Wang et al. established a discrimination model for Codonopsis Radix from different origins by data fusion of electronic nose and electronic tongue, effectively addressing the issue of imbalanced sample categories [61], which confirmed the practical value of sensory technologies in botanical origin identification. This study found that the odor differences between MCZ and BCZ were mainly captured by the W5S, W1W, and W1S sensors, suggesting that nitrogen oxides, terpenoids, inorganic sulfides, and short-chain alkanes play key roles in the formation of distinct odor profiles of the two origins. Further electronic tongue analysis indicated that sourness and richness were the key taste indicators for distinguishing MCZ from BCZ. This finding underscores the value of electronic tongue-based digital taste profiling as a complementary tool to conventional chemical analysis, as it can detect subtle sensor-level differences that may not correspond to human sensory perception but nonetheless contribute to multivariate discrimination. Moreover, correlation analysis revealed that the response of the W1S sensor was strongly correlated with several key volatile compounds such as linalool and carvone. This analysis further confirmed that short-chain oxygenated compounds and terpenoids are jointly responsible for the distinctive odor differences between the two origins. Specifically, compounds such as linalool, carvone, and (E)-caryophyllene contribute significantly to the characteristic odor profiles of MCZ and BCZ.
This study has certain limitations. First, the sample size was relatively small (six batches per origin), and more samples from different geographical regions are needed for validation. Second, the relationship between these chemical differences and pharmacological effects requires further investigation. Third, the discriminatory efficiency of the established fingerprinting method needs validation with more authentic reference samples. Fourth, since MCZ and BCZ were collected from different geographic regions, the observed chemical differences, including the identified key volatile markers, may be confounded by geographic origin and cultivation conditions rather than solely reflecting species differences. Environmental factors such as temperature, light, soil properties, and water availability are known to significantly influence secondary metabolite accumulation in medicinal plants [62,63,64], and substantial geographic variation in essential oil composition has been documented across different Atractylodes cultivation regions [65,66]. Controlled cultivation experiments with both species grown under identical environmental conditions would be necessary to confirm whether these markers are truly species-specific. The 2CV results further validated the reliability of the OPLS-DA models, indicating that the discrimination between BCZ and MCZ was not an artifact of overfitting but reflected genuine metabolic and sensory differences between the two species.
Future studies should expand sample collection to include batches from different cultivation conditions and harvest times. In addition, metabolomics combined with pharmacological experiments may further elucidate the relationship between chemical constituents and therapeutic effects.

4. Materials and Methods

4.1. Reagents

Optima-grade methanol and acetonitrile were purchased from Thermo Fisher Scientific (Waltham, MA, USA). Purified water was obtained from Guangzhou Watsons Food & Beverage Co., Ltd. (Guangzhou, China). All solvents were used without further purification.

4.2. Herbal Materials

A total of twelve batches of Atractylodis Rhizoma samples were used in this study, including six batches of MCZ and six batches of BCZ. The appearance characteristics of the herbal materials are shown in Figure 14, and the sample codes along with their geographical origins are provided in Table 4.
The MCZ samples were derived from Atractylodes lancea (Thunb.) DC., while the BCZ samples were derived from Atractylodes chinensis (DC.) Koidz. All samples were authenticated by Professor Fang Zhang from Shandong University of Traditional Chinese Medicine.

4.3. HS-GC-IMS Analysis

Analysis was performed using the FlavourSpec® GC-IMS (G.A.S., Dortmund, Germany). Precisely weigh 0.5 g each of powdered MCZ and BCZ, place the samples into 20 mL headspace vials with stoppers, and incubate at 80 °C for 15 min prior to injection. The system parameters were as follows: column temperature, 60 °C; carrier gas, N2; ion mobility detector temperature, 45 °C; total analysis time, 40 min. Injection volume was 200 μL, incubation time 15 min, incubation temperature 80 °C, injection needle temperature 80 °C, and incubation speed 500 rpm. E1 drift gas flow rate was 75 mL/min. E2 carrier gas flow rates were: 0–2 min, 2 mL/min; 2–10 min, 2–10 mL/min; 10–20 min, 10–100 mL/min; 20–25 min, 100–150 mL/min; 25–40 min, 150 mL/min. Qualitative analysis was conducted using the system’s built-in software, NIST database, and IMS migration time database. Component fingerprint profiles were generated using the Reporter and Gallery Plot plugins. Each sample was analyzed in triplicate.

4.4. UPLC-Orbitrap Analysis

4.4.1. Extraction of Non-Volatile Compounds

Pass the powders of MCZ and BCZ through a 60-mesh sieve. Accurately weigh 0.5 g of each sample, add exactly 20 mL of methanol, and weigh the mixture again to record its mass. Sonicate the mixture for 30 min, allow it to cool, and then reweigh. Add methanol to compensate for any weight loss, mix thoroughly, and transfer the solution to a 25 mL volumetric flask. Adjust to volume with methanol, filter the solution through a 0.22 µm microporous membrane, and store the resulting test solution at 4 °C in the dark until analysis. Each sample was prepared and analyzed in triplicate.

4.4.2. Instrumental Conditions

Analysis was performed using UPLC-Q-Exactive-Orbitrap-MS (Thermo Fisher Scientific, Waltham, MA, USA). Chromatographic conditions: Waters Acquity UPLC BEH C18 column (2.1 mm × 100 mm, 1.7 µm); mobile phase: A-water, B-acetonitrile, gradient elution; flow rate: 0.30 mL/min; column temperature: 30 °C; injection volume: 5 µL. The gradient elution program was as follows: 0–2 min, 5–30% B; 2–14 min, 30–60% B; 14–23 min, 60–70% B; 23–31 min, 70–95% B; 31–31.5 min, 95–5% B; 31.5–35 min, 5% B. MS conditions: Electrospray ionization (ESI) was performed in both positive and negative ion modes, scanning a mass range of m/z 50–1000. For negative ion mode, the optimized ESI parameters were as follows: capillary temperature, 350 °C; sheath gas (nitrogen) flow rate, 30 arb; auxiliary gas (nitrogen) flow rate, 10 arb; source voltage, 3.0 kV; capillary voltage, −35 V; tube lens voltage, −110 V. For positive ion mode: capillary voltage, 25 V; source voltage, 4.0 kV; tube lens voltage, 110 V; other parameters were the same as those for negative ion mode. The Orbitrap mass analyzer resolution was set to 30,000. The secondary mass spectrometer operated in data-dependent acquisition (DDA) mode with a normalized collision energy of 35%.

4.5. Electronic Nose Analysis

PEN3 electronic nose system (AIRSENSE Analytics GmbH, Schwerin, Germany) was used to analyze the odors of BCZ and MCZ. This system is equipped with 10 odor sensors (W1C, W5S, W3C, W6S, W5C, W1S, W1W, W2S, W2W, W3S). By evaluating each sensor’s sensitivity to various compound classes, the primary volatile odor characteristics of both Atractylodes species were identified. The response characteristics of the electronic nose sensors are listed in Table 5.
Accurately weigh 2.0 g of each BCZ and MCZ powder and transfer to headspace vials. Seal the vials with double-layer sealing membranes and allow them to equilibrate at room temperature for 20 min before analysis. The headspace inhalation method was used, with stable response values serving as the evaluation criterion. Sampling was performed every 1 s, with a cleaning time of 120 s, zero adjustment for 5 s, pre-sampling for 5 s, and a sampling duration of 120 s. The injection flow rate was set at 600 mL/min. For each batch, three samples were weighed and analyzed in triplicate.

4.6. Electronic Tongue Analysis

An SA-402B electronic tongue (Insent Intelligent Sensor Technology Inc., Atsugi, Japan) was used to analyze samples of BCZ and MCZ. The samples were ground and passed through a No. 4 sieve (65 mesh). Accurately weigh 1.0 g of the powdered sample and place it in a 250 mL stoppered conical flask. Add 150 mL of deionized water, shake well, and sonicate at 100 W for 30 min. Transfer the entire extract to a centrifuge tube and centrifuge at 3000 rpm for 20 min. Collect 35 mL of the supernatant and place it in a dedicated electronic tongue sample cup for analysis. The raw data were converted into taste values using the instrument’s built-in data processing software and exported for further analysis. Detailed information on the electronic tongue sensors is provided in Table 6.

4.7. Software and Statistical Analysis

Qualitative analysis of volatile components and construction of fingerprint profiles were carried out using the built-in database and plugins of the FlavourSpec® GC-IMS instrument. Principal Component Analysis (PCA) and Orthogonal Partial Least Squares Discriminant Analysis (OPLS-DA) were performed with SIMCA 14.1 software, and Variable Importance in Projection (VIP) values were calculated. Prism 10.1.2 was used to plot HS-GC-IMS component analysis charts; WinMuster software (AIRSENSE Analytics GmbH, Schwerin, Germany) was used to analyze electronic nose loadings plots; radar charts and stacked bar charts were created using Origin 2019b; and “component-odor” Pearson correlation analysis was conducted via the Microbioinformatics online platform. 2CV was performed using the pls package (version 2.9-0) in R (version 4.5.0). The outer loop employed leave-one-out cross-validation to assess prediction performance, while the inner loop utilized 7-fold cross-validation to optimize the number of orthogonal and predictive components. The 2CV Q2 was calculated based on the predicted versus observed Y values across all 12 iterations. Permutation tests (100 random permutations) were conducted to confirm the absence of overfitting.

5. Conclusions

In this study, a multi-dimensional analytical strategy integrating HS-GC-IMS, UPLC-Orbitrap MS, electronic nose, and electronic tongue was established to systematically characterize the differences between MCZ and BCZ.
HS-GC-IMS detected 108 volatile organic compounds, from which 24 volatile markers with VIP > 1.2 were screened as key contributors to the differentiation of MCZ and BCZ. Among them, propionic acid and 5-methyl-2-furancarboxaldehyde were mainly distributed in MCZ, whereas (E)-caryophyllene was present only or at higher levels in BCZ, indicating its potential as a characteristic volatile marker of BCZ. UPLC-Orbitrap MS detected 78 non-volatile constituents, and OPLS-DA screened 17 key non-volatile differential metabolites with VIP > 1.2, providing complementary chemical evidence for distinguishing the two origins. Electronic nose results revealed distinct odor profiles between MCZ and BCZ. Sensors W5S, W1W, and W1S were identified as the main differential sensors, suggesting that nitrogen oxides, terpenoids, inorganic sulfides, and short-chain alkanes are the primary contributors to the odor differences. Electronic tongue analysis demonstrated clear taste discrimination between the two origins, with sourness and richness identified as the key taste indicators.
Taken together, MCZ and BCZ can be clearly separated not only by sensory signals but also by both volatile and non-volatile chemical profiles. The integration of these four techniques provides a comprehensive and reliable strategy for distinguishing the two botanical origins of Atractylodis Rhizoma, offering scientific support for accurate authentication, quality evaluation, and rational clinical application. Future studies should expand sample collection to include batches from different geographic regions and cultivation conditions to further validate these markers.

Author Contributions

Conceptualization, H.Z. and Z.Q.; methodology, H.Z. and Y.H.; formal analysis, H.Z.; investigation, H.Z.; data curation, F.W.; writing—original draft preparation, H.Z.; writing—review and editing, Y.L.; funding acquisition, Y.L. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Young Scientists Fund of the National Natural Science Foundation of China (No. 82505122); Shandong Key Laboratory of Digital Traditional Chinese Medicine (No. 222025260); the Renowned Physicians and Classical Prescriptions Transformational Research and Development Program of Shandong University of Traditional Chinese Medicine (No. XK2025MY05); and the Youth Bian Que Scholars High-quality Development Program of Shandong University of Traditional Chinese Medicine (No. LIYANAN).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Kedi, L.; Zhangjing, C.; Hui, A. Research Progress on Chemical Components and Pharmacological Effects of Atractylodes. J. Chengdu Univ. Tradit. Chin. Med. 2024, 47, 73–80. [Google Scholar] [CrossRef]
  2. Xu, J.; Chen, D.; Liu, C.; Wu, X.-Z.; Dong, C.-X.; Zhou, J. Structural characterization and anti-tumor effects of an inulin-type fructan from Atractylodes chinensis. Int. J. Biol. Macromol. 2016, 82, 765–771. [Google Scholar] [CrossRef] [PubMed]
  3. Zhou, W.; Zheng, X.; Wang, X.; Tian, Y.; Wen, Y.; Tu, Y.; Lei, J.; Cheng, H.; Yu, J. Bioassay-guided isolation of antibacterial and anti-inflammatory components from Atractylodes lancea. Phytochemistry 2024, 227, 114232. [Google Scholar] [CrossRef] [PubMed]
  4. Hossen, M.J.; Amin, A.; Fu, X.-Q.; Chou, J.-Y.; Wu, J.-Y.; Wang, X.-Q.; Chen, Y.-J.; Wu, Y.; Li, J.; Yin, C.-L.; et al. The anti-inflammatory effects of an ethanolic extract of the rhizome of Atractylodes lancea, involves akt/NF-κB signaling pathway inhibition. J. Ethnopharmacol. 2021, 277, 114183. [Google Scholar] [CrossRef] [PubMed]
  5. Wang, D.; Dong, Y.; Xie, Y.; Xiao, Y.; Ke, C.; Shi, K.; Zhou, Z.; Tu, J.; Qu, L.; Liu, Y. Atractylodes lancea rhizome polysaccharide alleviates immunosuppression and intestinal mucosal injury in mice treated with cyclophosphamide. J. Agric. Food Chem. 2023, 71, 17112–17129. [Google Scholar] [CrossRef] [PubMed]
  6. Fei, Y.; Zhang, F.; Huang, D.; Xu, Q.; Jiang, T.; Xiao, L. Discussion on improving the quality standard of Atractylodis rhizoma and decoction pieces. Chin. J. Hosp. Pharm. 2023, 43, 887–891. [Google Scholar] [CrossRef]
  7. Ma, Z.; Liu, G.; Yang, Z.; Zhang, G.; Sun, L.; Wang, M.; Ren, X. Species differentiation and quality evaluation for Atractylodes medicinal plants by GC/MS coupled with chemometric analysis. Chem. Biodivers. 2023, 20, e202300793. [Google Scholar] [CrossRef] [PubMed]
  8. Li, C.; Wan, H.; Wu, X.; Yin, J.; Zhu, L.; Chen, H.; Song, X.; Han, L.; Yang, W.; Yu, H.; et al. Discrimination and characterization of the volatile organic compounds in Schizonepetae spica from six regions of China using HS-GC-IMS and HS-SPME-GC-MS. Molecules 2022, 27, 4393. [Google Scholar] [CrossRef] [PubMed]
  9. Wasilewski, T.; Migoń, D.; Gębicki, J.; Kamysz, W. Critical review of electronic nose and tongue instruments prospects in pharmaceutical analysis. Anal. Chim. Acta 2019, 1077, 14–29. [Google Scholar] [CrossRef] [PubMed]
  10. Luo, J.; Yuan, H.; Liang, L.; Xie, Q.; Jiang, S.; Fu, Y.; Chen, S.; Wang, W. An integrated strategy for quality control of the multi-origins herb medicine of Gentianae macrophyllae radix based on UPLC-orbitrap-MS/MS and HPLC-DAD. RSC Adv. 2023, 13, 8847–8862. [Google Scholar] [CrossRef] [PubMed]
  11. Huang, H.; Han, M.-H.; Gu, Q.; Wang, J.-D.; Zhao, H.; Zhai, B.-W.; Nie, S.-M.; Liu, Z.-G.; Fu, Y.-J. Identification of pancreatic lipase inhibitors from Eucommia ulmoides tea by affinity-ultrafiltration combined UPLC-orbitrap MS and in vitro validation. Food Chem. 2023, 426, 136630. [Google Scholar] [CrossRef] [PubMed]
  12. Brito, V.D.; Achimón, F.; Dambolena, J.S.; Pizzolitto, R.P.; Zygadlo, J.A. Trans-2-hexen-1-ol as a tool for the control of Fusarium verticillioides in stored maize grains. J. Stored Prod. Res. 2019, 82, 123–130. [Google Scholar] [CrossRef]
  13. Li, W.-R.; Zeng, T.-H.; Zhang, Z.-Q.; Shi, Q.-S.; Xie, X.-B. Geraniol attenuates virulence factors by inhibiting quorum sensing of pseudomonas aeruginosa. Front. Microbiol. 2023, 14, 1190619. [Google Scholar] [CrossRef] [PubMed]
  14. Yang, H.; Zhang, Y.; Cui, J.; Hao, Z. Apoptosis-mediated anticancer activity of geraniol inhibits NF-κB, MAPK, and JAK-STAT-3 signaling pathways in human thyroid cancer cells. Pharmacogn. Mag. 2022, 18, 1183–1189. [Google Scholar] [CrossRef]
  15. Liu, Y.; Zhou, S.; Huang, X.; Rehman, H.M. Mechanistic insight of the potential of geraniol against alzheimer’s disease. Eur. J. Med. Res. 2022, 27, 93. [Google Scholar] [CrossRef] [PubMed]
  16. Bagheri, S.; Rashno, M.; Salehi, I.; Karimi, S.A.; Raoufi, S.; Komaki, A. Protective effects of geraniol in a male rat model of Alzheimer’s disease: A behavioral, biochemical, and histological study. J. Alzheimer’s Dis. 2024, 102, 646–658. [Google Scholar] [CrossRef] [PubMed]
  17. Hassan, S.B.; Gali-Muhtasib, H.; Göransson, H.; Larsson, R. Alpha terpineol: A potential anticancer agent which acts through suppressing NF-κB signalling. Anticancer Res. 2010, 30, 1911–1919. [Google Scholar] [PubMed]
  18. Soleimani, M.; Sheikholeslami, M.A.; Ghafghazi, S.; Pouriran, R.; Parvardeh, S. Analgesic effect of α-terpineol on neuropathic pain induced by chronic constriction injury in rat sciatic nerve: Involvement of spinal microglial cells and inflammatory cytokines. Iran. J. Basic Med. Sci. 2019, 22, 1445–1451. [Google Scholar] [CrossRef] [PubMed]
  19. Rai, V.K.; Chanda, D.; Chanotiya, C.S.; Yadav, N.P. A combination of linalool and linalyl acetate synergistically alleviates imiquimod-induced psoriasis-like skin inflammation in BALB/c mice. Front. Pharmacol. 2022, 13, 913174. [Google Scholar] [CrossRef] [PubMed]
  20. Li, T.; Sun, X.; Chen, H.; He, B.; Mei, Y.; Wang, D.; Li, J. Methyl anthranilate: A novel quorum sensing inhibitor and anti-biofilm agent against Aeromonas sobria. Food Microbiol. 2020, 86, 103356. [Google Scholar] [CrossRef] [PubMed]
  21. Api, A.M.; Belsito, D.; Botelho, D.; Bruze, M.; Burton, G.A.; Cancellieri, M.A.; Chon, H.; Dagli, M.L.; Dekant, W.; Deodhar, C.; et al. RIFM fragrance ingredient safety assessment, ethyl p-anisate, CAS registry number 94-30-4. Food Chem. Toxicol. 2023, 176, 113789. [Google Scholar] [CrossRef] [PubMed]
  22. Letizia, C.S.; Cocchiara, J.; Lalko, J.; Api, A.M. Fragrance material review on linalyl isobutyrate. Food Chem. Toxicol. 2003, 41, 1005–1010. [Google Scholar] [CrossRef] [PubMed]
  23. Api, A.M.; Belsito, D.; Biserta, S.; Botelho, D.; Bruze, M.; Burton, G.A.; Buschmann, J.; Cancellieri, M.A.; Dagli, M.L.; Date, M.; et al. RIFM fragrance ingredient safety assessment, 4-ethylbenzaldehyde, CAS registry number 4748-78-1. Food Chem. Toxicol. 2020, 146, 111700. [Google Scholar] [CrossRef] [PubMed]
  24. Koohsari, S.; Sheikholeslami, M.A.; Parvardeh, S.; Ghafghazi, S.; Samadi, S.; Poul, Y.K.; Pouriran, R.; Amiri, S. Antinociceptive and antineuropathic effects of cuminaldehyde, the major constituent of cuminum cyminum seeds: Possible mechanisms of action. J. Ethnopharmacol. 2020, 255, 112786. [Google Scholar] [CrossRef] [PubMed]
  25. Morais, S.V.D.; Mendonça, P.G.; Vasconcelos, C.C.; Lopes, P.L.A.; Garcia, J.B.S.; Calzerra, N.T.M.; Queiroz, T.M.D.; Lima, S.T.D.J.R.M.; Silva, G.E.B.; Lopes, A.J.O.; et al. Cuminaldehyde effects in a MIA-induced experimental model osteoarthritis in rat knees. Metabolites 2023, 13, 397. [Google Scholar] [CrossRef] [PubMed]
  26. Monteiro-Neto, V.; De Souza, C.D.; Gonzaga, L.F.; Da Silveira, B.C.; Sousa, N.C.F.; Pontes, J.P.; Santos, D.M.; Martins, W.C.; Pessoa, J.F.V.; Carvalho Júnior, A.R.; et al. Cuminaldehyde potentiates the antimicrobial actions of ciprofloxacin against Staphylococcus aureus and Escherichia coli. PLoS ONE 2020, 15, e0232987. [Google Scholar] [CrossRef] [PubMed]
  27. Pang, J.; Jiang, Y.; Ma, S.; Xu, X.; Zhang, B.; Cai, Q. Analysis and Comparison of Volatile Oils from Four kinds of Atractylodes and Atractylodes macrocephala Koidz. by GC-MS. Asia-Pac. Tradit. Med. 2020, 16, 60–66. [Google Scholar]
  28. Zeng, H.; Gao, H.; Zhang, M.; Wang, J.; Gu, Y.; Wang, Y.; Zhang, H.; Liu, P.; Zhang, X.; Zhao, L. Atractylon treatment attenuates pulmonary fibrosis via regulation of the mmu_circ_0000981/miR-211-5p/TGFBR2 axis in an ovalbumin-induced asthma mouse model. Inflammation 2021, 44, 1856–1864. [Google Scholar] [CrossRef] [PubMed]
  29. Sun, S.; Shi, J.; Wang, X.; Huang, C.; Huang, Y.; Xu, J.; Cao, L.; Xie, T.; Wang, Y.; Huang, Z. Atractylon inhibits the tumorigenesis of glioblastoma through SIRT3 signaling. Am. J. Cancer Res. 2022, 12, 2310. [Google Scholar] [PubMed]
  30. Cho, W.; Nam, J.-W.; Kang, H.-J.; Windono, T.; Seo, E.-K.; Lee, K.-T. Zedoarondiol isolated from the rhizoma of curcuma heyneana is involved in the inhibition of iNOS, COX-2 and pro-inflammatory cytokines via the downregulation of NF-κB pathway in LPS-stimulated murine macrophages. Int. Immunopharmacol. 2009, 9, 1049–1057. [Google Scholar] [CrossRef] [PubMed]
  31. Chai, H.; Qu, H.; He, S.; Song, L.; Yang, Y.; Huang, H.; Shi, D. Zedoarondiol inhibits atherosclerosis by regulating monocyte migration and adhesion via CXCL12/CXCR4 pathway. Pharmacol. Res. 2022, 182, 106328. [Google Scholar] [CrossRef] [PubMed]
  32. Xiu, Z.; Zhu, Y.; Han, J.; Li, Y.; Yang, X.; Yang, G.; Song, G.; Li, S.; Li, Y.; Cheng, C.; et al. Caryophyllene oxide induces ferritinophagy by regulating the NCOA4/FTH1/LC3 pathway in hepatocellular carcinoma. Front. Pharmacol. 2022, 13, 930958. [Google Scholar] [CrossRef] [PubMed]
  33. Weimer, P.; Kreutz, T.; Limberger, R.P.; Rossi, R.C.; De Lima, Á.A.N.; Veiga, V.F.; De Araújo, B.V.; Koester, L.S. Correlation between the skin permeation profile of the synthetic sesquiterpene compounds, beta-caryophyllene and caryophyllene oxide, and the antiedematogenic activity by topical application of nanoemulgels. Biomolecules 2022, 12, 1102. [Google Scholar] [CrossRef] [PubMed]
  34. Shabana, S.M.; Gad, N.S.; Othman, A.I.; Mohamed, A.F.; El-Missiry, M.A. β caryophyllene oxide induces apoptosis and inhibits proliferation of A549 lung cancer cells. Med. Oncol. 2023, 40, 189. [Google Scholar] [CrossRef] [PubMed]
  35. Fidyt, K.; Fiedorowicz, A.; Strządała, L.; Szumny, A. β-caryophyllene and β-caryophyllene oxide—Natural compounds of anticancer and analgesic properties. Cancer Med. 2016, 5, 3007–3017. [Google Scholar] [CrossRef] [PubMed]
  36. Yao, Z.; Li, J.; Bian, L.; Li, Q.; Wang, X.; Yang, X.; Wei, X.; Wan, G.; Wang, Y.; Shi, J.; et al. Nootkatone alleviates rotenone-induced Parkinson’s disease symptoms through activation of the PI3K/akt signaling pathway. Phytother. Res. 2022, 36, 4183–4200. [Google Scholar] [CrossRef] [PubMed]
  37. Xu, Y.; Zhang, M.; Yang, W.; Xia, B.; Wang, W.; Pan, X. Nootkatone protects cartilage against degeneration in mice by inhibiting NF-κB signaling pathway. Int. Immunopharmacol. 2021, 100, 108119. [Google Scholar] [CrossRef] [PubMed]
  38. Gai, Y.; Bai, C.; Zhang, W.; Xiao, H.; Xu, J.; Hou, J.; Ge, X. Nootkatone attenuates airway inflammation in asthmatic mice through repressing ROS-induced NLRP3 inflammasome activation. Biochem. Cell Biol. 2023, 101, 513–522. [Google Scholar] [CrossRef] [PubMed]
  39. Cui, N.; Yang, H.; Chen, S.; Liu, S.; Xi, H.; Mei, D.; Sun, J. Nootkatone immunomodulates alveolar macrophage via STING/TBK1/IRF3 signaling pathway inhibition to protect against LPS-induced acute lung injury. Biochem. Pharmacol. 2025, 239, 117062. [Google Scholar] [CrossRef] [PubMed]
  40. Jha, A.K.; Gairola, S.; Kundu, S.; Doye, P.; Syed, A.M.; Ram, C.; Kulhari, U.; Kumar, N.; Murty, U.S.; Sahu, B.D. Biological activities, pharmacokinetics and toxicity of nootkatone: A review. Mini-Rev. Med. Chem. 2022, 22, 2244–2259. [Google Scholar] [CrossRef] [PubMed]
  41. Benali, T.; Bakrim, S.; Ghchime, R.; Benkhaira, N.; El Omari, N.; Balahbib, A.; Taha, D.; Zengin, G.; Hasan, M.M.; Bibi, S.; et al. Pharmacological insights into the multifaceted biological properties of quinic acid. Biotechnol. Genet. Eng. Rev. 2024, 40, 3408–3437. [Google Scholar] [CrossRef] [PubMed]
  42. Heikkilä, E.; Hermant, A.; Thevenet, J.; Bermont, F.; Kulkarni, S.S.; Ratajczak, J.; Santo-Domingo, J.; Dioum, E.H.; Canto, C.; Barron, D.; et al. The plant product quinic acid activates Ca2+-dependent mitochondrial function and promotes insulin secretion from pancreatic beta cells. Br. J. Pharmacol. 2019, 176, 3250–3263. [Google Scholar] [CrossRef] [PubMed]
  43. Yan, Y.; Li, Q.; Shen, L.; Guo, K.; Zhou, X. Chlorogenic acid improves glucose tolerance, lipid metabolism, inflammation and microbiota composition in diabetic db/db mice. Front. Endocrinol. 2022, 13, 1042044. [Google Scholar] [CrossRef] [PubMed]
  44. Xiao, N.; Zhang, T.; Han, M.; Tian, D.; Liu, J.; Li, S.; Yang, L.; Pan, G. Chlorogenic acid inhibits ceramide accumulation to restrain hepatic glucagon response. Nutrients 2023, 15, 3173. [Google Scholar] [CrossRef] [PubMed]
  45. Martínez, G.; Regente, M.; Jacobi, S.; Del Rio, M.; Pinedo, M.; De La Canal, L. Chlorogenic acid is a fungicide active against phytopathogenic fungi. Pestic. Biochem. Physiol. 2017, 140, 30–35. [Google Scholar] [CrossRef] [PubMed]
  46. Cortez, N.; Villegas, C.; Burgos, V.; Ortiz, L.; Cabrera-Pardo, J.R.; Paz, C. Therapeutic potential of chlorogenic acid in chemoresistance and chemoprotection in cancer treatment. Int. J. Med. Sci. 2024, 25, 5189. [Google Scholar] [CrossRef] [PubMed]
  47. Kzhyshkowska, J. Stabilizing the immune system by chlorogenic acid. J. Leukoc. Biol. 2022, 112, 7–8. [Google Scholar] [CrossRef] [PubMed]
  48. Eisha, S.; Morris, A.J.; Martin, I.; Yau, Y.C.W.; Grasemann, H.; Waters, V. Effect of L-arginine on cystic fibrosis Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 2024, 68, e00336-24. [Google Scholar] [CrossRef] [PubMed]
  49. Siani, A.; Pagano, E.; Iacone, R.; Iacoviello, L.; Scopacasa, F.; Strazzullo, P. Blood pressure and metabolic changes during dietary L-arginine supplementation in humans. Am. J. Hypertens. 2000, 13, 547–551. [Google Scholar] [CrossRef] [PubMed]
  50. Gao, Y.; Lu, J.; Wang, Z.; Sun, N.; Wu, B.; Han, X.; Liu, Y.; Yu, R.; Xu, Y.; Han, X.; et al. L-arginine attenuates Streptococcus uberis-induced inflammation by decreasing miR155 level. Int. Immunopharmacol. 2024, 130, 111638. [Google Scholar] [CrossRef] [PubMed]
  51. Huang, H.-C.; Lee, C.-R.; Weng, Y.-I.; Lee, M.-C.; Lee, Y.-T. Vasodilator effect of scoparone (6,7-dimethoxycoumarin) from a Chinese herb. Eur. J. Pharmacol. 1992, 218, 123–128. [Google Scholar] [CrossRef] [PubMed]
  52. Rong, N.; Yang, R.; Ibrahim, I.A.A.; Zhang, W. Cardioprotective role of scopoletin on isoproterenol-induced myocardial infarction in rats. Appl. Biochem. Biotechnol. 2023, 195, 919–932. [Google Scholar] [CrossRef] [PubMed]
  53. Zhang, W.; Zhao, W.; Ge, C.; Li, X.; Sun, Z. Scopoletin attenuates intracerebral hemorrhage-induced brain injury and improves neurological performance in rats. Neuroimmunomodulation 2021, 28, 74–81. [Google Scholar] [CrossRef] [PubMed]
  54. Fu, B.; Su, Y.; Ma, X.; Mu, C.; Yu, F. Scoparone attenuates angiotensin II-induced extracellular matrix remodeling in cardiac fibroblasts. J. Pharmacol. Sci. 2018, 137, 110–115. [Google Scholar] [CrossRef] [PubMed]
  55. Das, D.; Sarkar, S.; Bordoloi, J.; Wann, S.B.; Kalita, J.; Manna, P. Daidzein, its effects on impaired glucose and lipid metabolism and vascular inflammation associated with type 2 diabetes. BioFactors 2018, 44, 407–417. [Google Scholar] [CrossRef] [PubMed]
  56. Fang, X.; Lan, X.; Zhu, M.; He, M.; Sun, M.; Cao, Y.; Zhu, D.; Guo, D.; Luo, H. Puerarin induces macrophage M2 polarization to exert antinonalcoholic steatohepatitis pharmacological activity via the activation of autophagy. J. Agric. Food Chem. 2024, 72, 7187–7202. [Google Scholar] [CrossRef] [PubMed]
  57. Chang, K.; Linghang, Q.; Linghang, Q.; Yi, X.; Chunli, W.; Kang, X. Rhizoma atractylodis: A review on processing, chemical composition, pharmacological effects, and product development. Acupunct. Herb. Med. 2025, 5, 115–130. [Google Scholar] [CrossRef]
  58. Wang, S.; Chen, H.; Sun, B. Recent progress in food flavor analysis using gas chromatography–ion mobility spectrometry (GC–IMS). Food Chem. 2020, 315, 126158. [Google Scholar] [CrossRef] [PubMed]
  59. Hernández-Mesa, M.; Ropartz, D.; García-Campaña, A.M.; Rogniaux, H.; Dervilly-Pinel, G.; Le Bizec, B. Ion mobility spectrometry in food analysis: Principles, current applications and future trends. Molecules 2019, 24, 2706. [Google Scholar] [CrossRef] [PubMed]
  60. Gao, X.; Ma, D.; Li, K.; Xing, T.; Liu, X.; Peng, L.; Chen, D.; Hao, Z. Non-Targeted Metabolomics Combined with Chemometrics by UHPLC–Orbitrap–HRMS and Antioxidant Activity of Atractylodes chinensis (DC.) Koidez. from Eight Origins. Metabolites 2023, 13, 888–903. [Google Scholar] [CrossRef] [PubMed]
  61. Wang, S.; Lin, Z.; Zhang, B.; Du, J.; Li, W.; Wang, Z. Data fusion of electronic noses and electronic tongues aids in botanical origin identification on imbalanced Codonopsis Radix samples. Sci. Rep. 2022, 12, 19120. [Google Scholar] [CrossRef] [PubMed]
  62. Wang, H.; Wang, Y.; Kang, C.; Wang, S.; Zhang, Y.; Yang, G.; Zhou, L.; Xiang, Z.; Huang, L.; Liu, D.; et al. Drought stress modifies the community structure of root-associated microbes that improve Atractylodes lancea growth and medicinal compound accumulation. Front. Plant Sci. 2022, 13, 1032480. [Google Scholar] [CrossRef] [PubMed]
  63. Li, Y.; Kong, D.; Fu, Y.; Sussman, M.R.; Wu, H. The effect of developmental and environmental factors on secondary metabolites in medicinal plants. Plant Physiol. Biochem. 2020, 148, 80–89. [Google Scholar] [CrossRef] [PubMed]
  64. Pant, P.; Pandey, S.; Dall’Acqua, S. The influence of environmental conditions on secondary metabolites in medicinal plants: A literature review. Chem. Biodivers. 2021, 18, e2100345. [Google Scholar] [CrossRef] [PubMed]
  65. Song, B.; Wang, W.; Liu, R.; Cai, J.; Jiang, Y.; Tang, X.; Wu, H.; Ao, H.; Chen, L. Geographic differentiation of essential oil from rhizome of cultivated Atractylodes lancea by using GC-MS and chemical pattern recognition analysis. Molecules 2023, 28, 2216. [Google Scholar] [CrossRef] [PubMed]
  66. Zhang, C.; Wang, H.; Lyu, C.; Wang, Y.; Sun, J.; Zhang, Y.; Xiang, Z.; Guo, X.; Wang, Y.; Qin, M.; et al. Authenticating the geographic origins of Atractylodes lancea rhizome chemotypes in China through metabolite marker identification. Front. Plant Sci. 2023, 14, 1237800. [Google Scholar] [CrossRef] [PubMed]
Figure 1. 3D gas-phase ion mobility spectrum comparison.
Figure 1. 3D gas-phase ion mobility spectrum comparison.
Molecules 31 02350 g001
Figure 2. Differential comparison spectra.
Figure 2. Differential comparison spectra.
Molecules 31 02350 g002
Figure 3. Composition of major volatile metabolites. (a) Pie chart of relative volatile metabolite content; (b) alcohols; (c) esters; (d) aldehydes.
Figure 3. Composition of major volatile metabolites. (a) Pie chart of relative volatile metabolite content; (b) alcohols; (c) esters; (d) aldehydes.
Molecules 31 02350 g003
Figure 4. Component fingerprint profiles.
Figure 4. Component fingerprint profiles.
Molecules 31 02350 g004
Figure 5. PCA and OPLS-DA based on HS-GC-IMS data. (a) PCA score plot; (b) OPLS-DA score plot; (c) permutation test; (d) VIP values.
Figure 5. PCA and OPLS-DA based on HS-GC-IMS data. (a) PCA score plot; (b) OPLS-DA score plot; (c) permutation test; (d) VIP values.
Molecules 31 02350 g005aMolecules 31 02350 g005b
Figure 6. Total ion current chromatogram of non-volatile metabolites.
Figure 6. Total ion current chromatogram of non-volatile metabolites.
Molecules 31 02350 g006
Figure 7. PCA and OPLS-DA based on UPLC-Orbitrap data. (a) PCA score plot; (b) OPLS-DA score plot; (c) Permutation test; (d) VIP values.
Figure 7. PCA and OPLS-DA based on UPLC-Orbitrap data. (a) PCA score plot; (b) OPLS-DA score plot; (c) Permutation test; (d) VIP values.
Molecules 31 02350 g007aMolecules 31 02350 g007b
Figure 8. Radar plots of Atractylodes sensor responses. (a) Radar plot of MCZ sensor responses; (b) radar plot of BCZ sensor responses.
Figure 8. Radar plots of Atractylodes sensor responses. (a) Radar plot of MCZ sensor responses; (b) radar plot of BCZ sensor responses.
Molecules 31 02350 g008
Figure 9. Analysis of sensor discrimination contribution rates.
Figure 9. Analysis of sensor discrimination contribution rates.
Molecules 31 02350 g009
Figure 10. OPLS-DA based on electronic nose data. (a) OPLS-DA score plot; (b) permutation test; (c) VIP values.
Figure 10. OPLS-DA based on electronic nose data. (a) OPLS-DA score plot; (b) permutation test; (c) VIP values.
Molecules 31 02350 g010
Figure 11. Electronic tongue sensor response values.
Figure 11. Electronic tongue sensor response values.
Molecules 31 02350 g011
Figure 12. PCA and OPLS-DA based on electronic tongue data. (a) PCA score plot; (b) OPLS-DA score plot; (c) permutation test; (d) VIP values.
Figure 12. PCA and OPLS-DA based on electronic tongue data. (a) PCA score plot; (b) OPLS-DA score plot; (c) permutation test; (d) VIP values.
Molecules 31 02350 g012aMolecules 31 02350 g012b
Figure 13. Correlation analysis plot (* p < 0.05).
Figure 13. Correlation analysis plot (* p < 0.05).
Molecules 31 02350 g013
Figure 14. (AF) are MCZ1–MCZ6; (GL) are BCZ1–BCZ6.
Figure 14. (AF) are MCZ1–MCZ6; (GL) are BCZ1–BCZ6.
Molecules 31 02350 g014
Table 1. Identification of volatile metabolites in Atractylodes of different origins using gas-phase ion mobility spectrometry.
Table 1. Identification of volatile metabolites in Atractylodes of different origins using gas-phase ion mobility spectrometry.
ClassCompoundCASFormulaMWRIRt [sec]Dt [a.u.]Differential Components
AlcoholGeraniol106-24-1C10H18O154.31837.91136.691.21
(Z)-4-Decen-1-ol57074-37-0C10H20O156.31786.61061.731.44
Propylene glycol57-55-6C3H8O276.11586.9814.131.27
Cedrol77-53-2C15H26O222.41555.7780.981.43
Linalool oxide1365-19-1C10H18O2170.31465.3692.551.67
2-Hexen-1-ol2305-21-7C6H12O100.21395.0628.381.19
(E)-3-Hexen-1-ol928-97-2C6H12O100.21350.9542.581.25C5
α-Terpineol98-55-5C10H18O154.31283.5433.411.22C8
2-Butyl-1-octanol3913-02-8C12H26O186.31277.2424.231.67
4-Methoxybenzyl alcohol105-13-5C8H10O2138.21244.7380.091.08C11
cis-3,7-Dimethyl-octa-2,6-dien-1-ol-M(FCC)624-15-7C10H18O154.31219.4349.031.22
FCC dimer624-15-7C10H18O154.31217.2346.371.64C1
3,7-Dimethyl-1-octanol106-21-8C10H22O158.31200.1327.031.57
(–)-4-Terpineol20126-76-5C10H18O154.31178.5304.861.22
1-Penten-3-ol616-25-1C5H10O86.11155.0282.940.94
2-Pentanol6032-29-7C5H12O88.11153.9281.931.44C21
β-Linalool78-70-6C10H18O154.31098.7236.611.21
1,8-Cineole470-82-6C10H18O154.31027.2203.951.29
2-Hexanol626-93-7C6H14O102.2966.5179.991.28
Isopropyl alcohol67-63-0C3H8O60.1942.9171.441.09
2-Butoxyethanol111-76-2C6H14O2118.2895.0155.341.20
Aldehyde(E)-2-Decenal3913-81-3C10H18O154.31635.7868.641.47
(E,Z)-2,6-Nonadienal557-48-2C9H14O138.21583.7810.641.37
5-Methylfurfural620-02-0C6H6O2110.11555.7780.971.13
Undecanal112-44-7C11H22O170.31316.3483.491.594
3,7-Dimethyl-2,6-octadienal5392-40-5C10H16O152.21267.6410.701.042
Cuminaldehyde122-03-2C10H12O148.21242.5377.251.330
(E)-2-Hexenal6728-26-3C6H10O98.11207.2334.861.173C18
4-Ethylbenzaldehyde4748-78-1C9H10O134.21199.9326.741.271
(E)-2-Octenal2548-87-0C8H14O126.21024.5202.821.328
3-Methylbutanal590-86-3C5H10O86.1921.3164.001.194C6
(E,E)-2,4-Hexadienal142-83-6C6H8O96.1907.6159.441.114
(Z)-4-Heptenal6728-31-0C7H12O112.2881.9151.201.145
Furfural98-01-1C5H4O296.1845.2140.211.089
Ketone2,4-Dimethylcyclopentan-1,3-dione13494-06-9C7H10O2126.21900.21234.981.204
2-Hydroxy-3-methyl-2-cyclopenten-1-one80-71-7C6H8O2112.11834.61131.771.520C22
3-Methyl-2(5H)-furanone22122-36-7C5H6O298.11798.01078.041.381
3-Methyl-2-cyclopenten-1-one2758-18-1C6H8O96.11516.2741.061.109
2-Nonanone821-55-6C9H18O142.21414.0646.871.405
6-Methyl-5-hepten-2-one110-93-0C8H14O126.21335.2514.891.184
Hydroxyacetone116-09-6C3H6O274.11299.0456.561.043
Carvone (monomer)2244-16-8C10H14O150.21261.2401.891.303C2
Carvone (dimer)2244-16-8C10H14O150.21260.1400.371.831
2-Hexanone591-78-6C6H12O100.21106.3242.391.191
2,3-Pentanedione1629-58-9C5H8O84.11005.0194.831.075
2-Octanone111-13-7C8H16O128.2982.5186.011.335C24
2-Butanone78-93-3C4H8O72.1941.1170.821.059C13
Cyclopentanone120-92-3C5H8O84.1810.1130.421.102
Carboxylic acid(E)-3-Hexenoic acid1577-18-0C6H10O2114.11955.51329.311.229C20
Heptanoic acid111-14-8C7H14O2130.21918.81265.871.369
Propanoic acid79-09-4C3H6O274.11491.6717.121.105
Hexanoic acid142-62-1C6H12O2116.21001.0193.221.293
Esterγ-Decalactone706-14-9C10H18O2170.32119.51653.171.494
Benzyl phenylacetate140-11-4C16H16O2240.31713.1962.891.326
Citronellyl formate105-85-1C11H20O2184.31615.7845.861.335
Furfuryl acetate623-17-6C7H8O3140.11535.5760.281.411C9
Propylene glycol diacetate623-84-7C7H12O4160.21487.6713.361.216
Ethyl 4-methoxybenzoate94-30-4C10H12O3180.21405.9639.931.331
Benzyl isobutyrate (dimer)103-48-0C12H16O2192.31390.6619.091.976
Benzyl isobutyrate (monomer)103-48-0C12H16O2192.31390.0617.961.393
Linalyl isobutyrate (monomer)78-35-3C14H24O2224.31355.0549.961.218C3
Linalyl isobutyrate (dimer)78-35-3C14H24O2224.31351.9544.341.696
Ethyl 2-hydroxypropanoate97-64-3C5H10O3118.11337.1518.221.133
Methyl anthranilate134-20-3C8H9NO2151.21297.5454.171.264C7
Methyl heptanoate106-73-0C8H16O2144.21297.1453.621.360
Linalyl acetate115-95-7C12H20O2196.31260.9401.501.212
β-Methyl-γ-octalactone39212-23-2C9H16O2156.21201.2328.211.371
1-Phenylethyl acetate93-92-5C10H12O2164.21192.4318.601.049C14
Methyl phenylacetate101-41-7C9H10O2150.21154.0282.031.255
2-Methylbutyl acetate624-41-9C7H14O2130.21128.7260.221.292
Tetrahydrofurfuryl acetate637-64-9C7H12O3144.21099.1236.911.180
3-Methylbutyl 2-methylbutanoate27625-35-0C10H20O2172.31098.6236.521.423
γ-Hexalactone695-06-7C6H10O2114.11064.6220.291.185
Prenyl acetate1191-16-8C7H12O2128.2932.5167.820.944
Butyl propionate590-01-2C7H14O2130.2893.6154.881.282
Alkene(E,E)-α-Farnesene502-61-4C15H24204.41735.7992.261.435C10
(E)-Caryophyllene87-44-5C15H24204.41383.1603.821.424C19
Limonene138-86-3C10H16136.21233.6366.141.218
Naphthalene91-20-3C10H8128.21155.6283.441.113
δ-3-Carene13466-78-9C10H16136.21143.1272.391.216C16
α-Phellandrene99-83-2C10H16136.21014.0198.491.221
PhenolMethyl eugenol93-15-2C11H14O2178.22040.91489.051.443C15
Butylated hydroxytoluene (monomer)128-37-0C15H24O220.41517.8742.641.329
Butylated hydroxytoluene (dimer)128-37-0C15H24O220.41496.9722.251.331C17
Ethyl vanillin121-32-4C9H10O3166.21428.7659.581.278
4-vinyl-2-methoxyphenol (monomer)7786-61-0C9H10O2150.21319.6488.951.218
4-vinyl-2-methoxyphenol (dimer)7786-61-0C9H10O2150.21319.2488.221.732
4-Vinylguaiacol7786-61-0C9H10O2150.21290.7443.971.218C12
Methyl salicylate119-36-8C8H8O3152.11163.4290.541.204
N-containing2-Methoxy-3-sec-butylpyrazine24168-70-5C9H14N2O166.21516.4741.241.249C23
2-Ethyl-3-methylpyrazine15707-23-0C7H10N2122.21434.0664.251.161
Pyrazine290-37-9C4H4N280.11211.5339.851.044
N-Ethyl-2-pyrrolidone2687-91-4C6H11NO113.21152.9281.061.154
N,N-Dimethylaniline121-69-7C9H13N135.21015.9199.241.225
2-Ethylpyridine100-71-0C7H9N107.2969.1180.941.098
1-Methyl-1H-pyrrole-2-carboxaldehyde1192-58-1C6H7NO109.1966.1179.851.121
S-containing5-Methyl-2-thiophenecarboxaldehyde13679-70-4C6H6OS126.21129.1260.601.179
Ethyl thioacetate625-60-5C4H8OS104.21117.4251.121.131
2,5-Dimethylthiophene638-02-8C6H8S112.2885.6152.361.070
Dimethyl disulfide624-92-0C2H6S294.2737.7112.351.140
OtherN,N-Dimethylacetamide127-19-5C4H9NO87.11434.2664.431.063
N,N-Dimethylformamide68-12-2C3H7NO73.11372.6583.211.252C4
Dihydrocoumarin119-84-6C9H8O2148.21352.3545.041.287
Anethole4180-23-8C10H12O148.21288.2440.291.761
Triethyl phosphate78-40-0C6H15O4P182.21138.1268.171.299
Octamethylcyclotetrasiloxane556-67-2C8H24O4Si4296.61004.1194.491.676
2-Pentylfuran3777-69-3C9H14O138.21001.7193.511.246
4-Methylanisole104-93-8C8H10O122.2993.5190.291.116
Table 2. Chemical composition of non-volatile metabolites in Atractylodes.
Table 2. Chemical composition of non-volatile metabolites in Atractylodes.
ClassNameFormulaDeltaMass [ppm]MWm/zRT [min]Fragment Ions
FlavonoidsNobiletinC21H22O8−1.67402.13403.1416.27403.14, 388.11
DaidzeinC15H10O4−1.22254.06255.069.64255.06, 227.07
LignansMatairesinolC20H22O6−1.46358.14359.159.64323.12, 291.1
(3R,4R)-4-[(3,4-dimethoxyphenyl)methyl]-3-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-oneC21H24O6−1.49372.16373.1611.39306.12, 237.11
Others2,4-di-tert-ButylphenolC14H22O−0.3206.17205.1626.42206.16, 205.16
trans-3-Indoleacrylic acidC11H9NO2−1.81187.06188.073.1188.07, 170.07
1,2,3,4-Tetramethyl-1,3-cyclopentadieneC9H14−2122.11123.1226.99123.12, 95.09
(±)-CannabichromeorcinC17H22O2−0.84258.16259.1714.8259.17, 203.11
Sugars and their glycosidesGluconic acidC6H12O7−0.79196.06195.051.07195.05, 177.04
α,α-TrehaloseC12H22O11−0.79342.12341.111.13341.11, 179.06
PuerarinC21H20O9−0.84416.11417.124.17381.1, 363.09
3-Ethyl-4-hydroxy-4-methylpentyl 6-O-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)tetrahydro-2-furanyl]-β-D-glucopyranosideC19H36O11−0.17440.23439.225.42307.18, 161.05
5′-S-Methyl-5′-thioadenosineC11H15N5O3S−1.44297.09298.14.32136.06, 61.01
D-(−)-FructoseC6H12O6−0.94180.06179.061.08179.07, 161.05
2′-O-MethyladenosineC11H15N5O4−1.71281.11282.123.23283.17, 282.12
8-Hydroxy-6-methoxy-2-oxo-2H-chromen-7-yl β-D-glucopyranosideC16H18O10−0.37370.09369.083.8354.06, 207.03
TerpenoidsNootkatoneC15H22O−2.18218.17219.1712.51219.17, 163.11
(−)-Caryophyllene oxideC15H24O−1.48220.18221.1917.97221.19, 203.18
(3aS,5aR,6R,9aS,9bS)-6-hydroxy-5a-methyl-3,9-dimethylidene-dodecahydronaphtho[1,2-b]furan-2-oneC15H20O3−1.45248.14249.1510.71249.15, 231.14
(3aR,5aR,9bR)-3a-hydroxy-5a,9-dimethyl-3-methylidene-2H,3H,3aH,4H,5H,5aH,6H,7H,8H,9bH-naphtho[1,2-b]furan-2-oneC15H20O3−1.06248.14249.1514.52249.15, 231.14
(3aR,4aS,5R,7aS,8S,9aR)-5-Hydroxy-4a,8-dimethyl-3-methyleneoctahydroazuleno[6,5-b]furan-2,6(3H,4H)-dioneC15H20O4−1.57264.14265.144.8265.14, 229.12
(3aR,7aS,8S,9aR)-5,8-dimethyl-3-methylidene-2H,3H,3aH,4H,6H,7H,7aH,8H,9H,9aH-azuleno[6,5-b]furan-2,6-dioneC15H18O3−1.18246.13247.1312.69247.13, 229.12
Ambrosic acidC15H20O4−1.54264.14265.147.37265.14, 229.12
6-hydroxy-3,5a,9-trimethyl-2H,3H,3aH,4H,5H,5aH,6H,7H,9aH,9bH-naphtho[1,2-b]furan-2-oneC15H22O3−1.51250.16251.1611.42233.15, 187.15
ZedoarondiolC15H24O3−1.38252.17253.189.47235.17, 217.16
D,L-CamphorC10H16O−1.69152.12153.138.29153.13, 135.09
(5E)-7-methylidene-10-oxo-4-(propan-2-yl)undec-5-enoic acidC15H24O3−1.41252.17253.188.34235.17, 217.16
AtractyloneC15H20O−1.74216.15217.1618.62217.16, 175.15
Atractylenolide IVC17H22O5−2.12306.15307.1516.31290.15, 215.11
AtractylodinolC13H10O2−3.01198.08199.0719.06290.15, 215.11
MusconeC16H30O−1.86238.23239.2428.75239.24, 151.15
AmidesHexadecanamideC16H33NO−2.31255.26256.2631.62257.27, 116.11
OleamideC18H35NO−1.7281.27282.2828.03282.28, 149.13
StearamideC18H37NO−0.94283.29284.2933.11284.29, 172.17
ErucamideC22H43NO−1.98337.33338.3431.59338.34, 303.31
Linoleoyl ethanolamideC20H37NO2−2.06323.28324.2930.17306.28, 161.13
CoumarinsScopoletinC10H8O4−1.48192.04191.035.16193.05, 178.03
ScoparoneC11H10O4−2.15206.06207.066.43207.06, 192.04
4-HydroxycoumarinC9H6O3−0.72162.03161.025.23161.02, 162.03
FraxetinC10H8O5−1.44208.04209.044.52209.04, 194.02
Organic acids and their estersDL-Malic acidC4H6O5−0.55134.02133.011.44133.01, 115
DL-ArginineC6H14N4O2−1.8174.11175.121.66175.12, 158.09
D-(+)-TryptophanC11H12N2O2−0.65204.09203.083.1203.08, 159.09
ProlineC5H9NO2−2.36115.06116.071.09116.07, 117.07
IsoleucineC6H13NO2−1.74131.09132.11.53132.1, 87.09
Salicylic acidC7H6O3−0.46138.03137.023.51138.03, 137.02
4-Feruloylquinic acidC17H20O9−0.1368.11367.13.35193.05, 173.05
Benzoic acidC7H6O2−0.27122.04121.033.46121.03, 122.02
D-(−)-Quinic acidC7H12O6−0.37192.06191.062.37191.06, 173.05
α-Eleostearic acidC18H30O2−2.22278.22279.2327.23279.23, 173.13
4,5-Dicaffeoylquinic acidC25H24O12−0.1516.13515.124.96353.1, 191.06
Picolinic acidC6H5NO2−0.91123.03122.023.16122.02, 94.03
Neochlorogenic acidC16H18O9−0.32354.09353.094.71191.06, 179.03
Chlorogenic acidC16H18O9−0.31354.09353.092.48191.06, 179.04
3-Furoic acidC5H4O3−0.81112.02111.011.23111.01, 67.02
CatecholC6H6O2−0.44110.04109.033.46109.03, 108.02
Pentadecanoic acidC15H30O2−0.64242.22241.2231.68241.22, 129.23
16-Hydroxyhexadecanoic acidC16H32O3−0.44272.24271.2327.1271.23, 235.22
(+/−)9,10-dihydroxy-12Z-octadecenoic acidC18H34O40.1314.25313.2424.35313.24, 295.23
Caffeic acidC9H8O4−0.33180.04179.032.88179.03, 135.05
Nervonic acidC24H46O2−0.74366.35365.3432.28365.34, 366.35
9-Oxo-10(E),12(E)-octadecadienoic acidC18H30O3−0.86294.22295.2326.65277.22, 165.13
Vanillic acidC8H8O4−0.52168.04167.032.71167.03, 152.01
Syringic acidC9H10O5−0.54198.05197.052.55197.05, 182.02
(±)13-HODEC18H32O3−0.91296.23295.2328.09295.23, 277.22
8Z,11Z,14Z-Eicosatrienoic acidC20H34O2−0.38306.26305.2532305.25, 306.35
Corchorifatty acid FC18H32O50.38328.23327.2214.56327.22, 239.13
(±)9-HpODEC18H32O40.12312.23311.2223.23311.22, 293.21
1-Linoleoyl glycerolC21H38O4−1.87354.28355.2830.81285.01, 263.24
13(S)-HOTrEC18H30O3−0.81294.22295.2323.18277.22, 165.13
Methyl salicylateC8H8O3−0.35152.05151.046.94151.04, 136.02
Citric acidC6H8O7−0.55192.03191.021.44191.06, 129.02
2-Methylbenzoic acidC8H8O2−0.57136.05135.056.6136.05, 135.05
3-Hydroxypicolinic acidC6H5NO3−1.44139.03140.034.26183.08, 165.07
(15Z)-9,12,13-Trihydroxy-15-octadecenoic acidC18H34O5−0.22330.24329.2316.01329.23, 311.22
trans-10-Heptadecenoic acidC17H32O2−0.05268.24267.2331.95267.23, 249.22
Methyl cinnamateC10H10O2−2.18162.07163.0815.91163.07, 131.05
9-Oxo-ODEC18H30O3−1.03294.22295.2328.67277.22, 165.13
Table 3. Double cross-validation (2CV) results for OPLS-DA models.
Table 3. Double cross-validation (2CV) results for OPLS-DA models.
ModelQ2 (2CV)Permutation Q2 InterceptAccuracy
Electronic nose0.624−1.68091.67%
Electronic tongue0.996−1.621100%
HS-GC-IMS0.880−2.281100%
UPLC-Orbitrap MS 0.878−1.269100%
Table 4. Herbal material information table.
Table 4. Herbal material information table.
No.OriginNo.Origin
MCZ-1Yingshan County, Hubei ProvinceBCZ-1Chifeng City, Inner Mongolia Autonomous Region
MCZ-2Yingshan County, Hubei ProvinceBCZ-2Chifeng City, Inner Mongolia Autonomous Region
MCZ-3Yingshan County, Hubei ProvinceBCZ-3Hulunbuir City, Inner Mongolia Autonomous Region
MCZ-4Shiyan City, Hubei ProvinceBCZ-4Hulunbuir City, Inner Mongolia Autonomous Region
MCZ-5Shiyan City, Hubei ProvinceBCZ-5Chengde City, Hebei Province
MCZ-6Shiyan City, Hubei ProvinceBCZ-6Chengde City, Hebei Province
Table 5. Electronic nose sensor information table.
Table 5. Electronic nose sensor information table.
Serial NumberSensor NameRepresentative Compound Categories
R (1)W1CSensitive to aromatic compounds and benzene compounds
R (2)W5SHigh sensitivity, highly responsive to nitrogen oxides
R (3)W3CSensitive to amines and aromatic compounds
R (4)W6SPrimarily selective for hydrides
R (5)W5CAlkane and aromatic components
R (6)W1SSensitive to methane and other short-chain alkanes
R (7)W1WSensitive to terpenes and inorganic sulfides
R (8)W2SSensitive to alcohols, aldehydes, and ketones
R (9)W2WAromatic compounds, sensitive to organic sulfides
R (10)W3SSensitive to alkanes, long-chain alkanes
Table 6. Information on electronic tongue sensors.
Table 6. Information on electronic tongue sensors.
SensorTasteAftertaste
Umami (AAE)UmamiRichness
Salty (CTO)Salty-
Acidity (CAO)Acidity-
Bitterness (COO)BitternessBitter aftertaste
Astringency (AE1)AstringencyAstringent aftertaste
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Zhang, H.; Qu, Z.; Wang, F.; Han, Y.; Li, Y. Characteristic Constituents of Maocangzhu and Beicangzhu Revealed Using Electronic Nose, Electronic Tongue, HS-GC-IMS, and UPLC-Orbitrap Technologies. Molecules 2026, 31, 2350. https://doi.org/10.3390/molecules31132350

AMA Style

Zhang H, Qu Z, Wang F, Han Y, Li Y. Characteristic Constituents of Maocangzhu and Beicangzhu Revealed Using Electronic Nose, Electronic Tongue, HS-GC-IMS, and UPLC-Orbitrap Technologies. Molecules. 2026; 31(13):2350. https://doi.org/10.3390/molecules31132350

Chicago/Turabian Style

Zhang, Hanqi, Zhenni Qu, Fan Wang, Yutong Han, and Yanan Li. 2026. "Characteristic Constituents of Maocangzhu and Beicangzhu Revealed Using Electronic Nose, Electronic Tongue, HS-GC-IMS, and UPLC-Orbitrap Technologies" Molecules 31, no. 13: 2350. https://doi.org/10.3390/molecules31132350

APA Style

Zhang, H., Qu, Z., Wang, F., Han, Y., & Li, Y. (2026). Characteristic Constituents of Maocangzhu and Beicangzhu Revealed Using Electronic Nose, Electronic Tongue, HS-GC-IMS, and UPLC-Orbitrap Technologies. Molecules, 31(13), 2350. https://doi.org/10.3390/molecules31132350

Article Metrics

Back to TopTop